The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. - Wikidata - awgldk - TriplyDB

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

http://www.wikidata.org/entity/Q35066321

about

TCF/LEF Transcription Factors: An Update from the Internet Resources Endogenous retroviral promoter exaptation in human cancer The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation Precision targeted therapy of ovarian cancer The biorepository portal toolkit: an honest brokered, modular service oriented software tool set for biospecimen-driven translational research CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms How Can We Treat Cancer Disease Not Cancer Cells?Joint analysis of multiple high-dimensional data types using sparse matrix approximations of rank-1 with applications to ovarian and liver cancer Identification of Biomarkers for Breast Cancer Using Databases.Genomic profiling reveals mutational landscape in parathyroid carcinomas The Mutational Landscape of the Oncogenic MZF1 SCAN Domain in Cancer.ICM: a web server for integrated clustering of multi-dimensional biomedical data MUFFINN: cancer gene discovery via network analysis of somatic mutation data.Dissecting the biological relationship between TCGA miRNA and mRNA sequencing data using MMiRNA-Viewer.Flexible model-based clustering of mixed binary and continuous data: application to genetic regulation and cancer.Mutations of Chromatin Structure Regulating Genes in Human Malignancies.Establishment of a Strong Link Between Smoking and Cancer Pathogenesis through DNA Methylation Analysis.RNA-Seq based genome-wide analysis reveals loss of inter-chromosomal regulation in breast cancer.Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.Transcriptomic analyses of RNA-binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma.Pan-cancer analysis reveals technical artifacts in TCGA germline variant calls MYC Deregulation in Primary Human Cancers.BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.Dietary MicroRNA Database (DMD): An Archive Database and Analytic Tool for Food-Borne microRNAs Use of semantic workflows to enhance transparency and reproducibility in clinical omics.ExSurv: A Web Resource for Prognostic Analyses of Exons Across Human Cancers Using Clinical Transcriptomes.Comprehensive comparison of molecular portraits between cell lines and tumors in breast cancer.Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.The ability of human nuclear DNA to cause false positive low-abundance heteroplasmy calls varies across the mitochondrial genome.DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations.Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer Developmental genes significantly afflicted by aberrant promoter methylation and somatic mutation predict overall survival of late-stage colorectal cancer.Special Section Guest Editorial:Radiomics and Imaging Genomics: Quantitative Imaging for Precision Medicine Extracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome.Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.A microscopic landscape of the invasive breast cancer genome A bioinformatics approach for precision medicine off-label drug drug selection among triple negative breast cancer patients.Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer.Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients

P2860

Q26742019-C79036F0-6DB4-4C60-B1B3-B081DF34337F Q28067477-EC3B3EBB-A87B-4513-AAFE-71C7C48F9B34 Q28075374-691029EF-8BD2-4D5F-8026-78F710942374 Q28078658-79165521-7838-4644-8F28-2813332C3020 Q28387672-B782E117-485D-40D9-B978-95C59DBA1F21 Q28392625-F1ADF042-F730-4748-AD55-7EEF47887516 Q28558823-217F24C0-4F6D-48AB-8288-02BFA5AC7849 Q28595658-7A4ECD28-E6F4-4898-915E-0CCB82BCE057 Q30239810-4E51175A-63C6-403C-8707-C721C7421E0D Q30360213-F6B043A4-2C14-4C21-8FD0-8C818DB7B510 Q30396819-31555E54-6CD5-490C-BC6C-90C5C9F3C079 Q31088370-B9D9EC49-9668-4153-8B53-1AABEE335407 Q31110093-0A0E74CF-077E-4EA4-BBEE-CF89AE93A66A Q31138229-84F47407-8786-4979-A635-15F5D75DE4A8 Q31150084-F55FA66F-A64E-4253-914A-E04BFE55E2B9 Q33600399-A45CE0EA-0981-4EB0-BD5C-0809522F546E Q33687347-119A7D89-143D-447E-927A-6A32C4D958C3 Q33687763-99F9EC16-ACED-49C3-AC7E-3ADB63F90BBE Q33709494-8F649161-F2F9-49B4-87EA-39C593E959AA Q33738850-E57B5CFF-1214-47B2-9FD0-F377DE19AD5F Q33786614-8E495212-DCF2-4850-A4AC-671F470E1CAC Q33836755-8768C2FC-152F-466A-82B0-D63D98691598 Q33894431-57980883-44EB-471C-B6BE-CE102C8592E5 Q35648299-FB3B646A-C2D2-4996-85D1-123A27F0758C Q35985522-F297E68C-C240-4867-A37C-EB5CCB72A85E Q36104742-43F53622-4E70-42B2-BB77-183650A77A5B Q36111215-C92B4011-DAB5-4869-ADDE-FA3913E7371E Q36112218-1AAAE7C9-24F8-4E6E-B561-0A2F5B4C276A Q36220707-C05DA1EF-7945-462B-B9A8-E490F11C5A6A Q36268659-2ACEF4AA-8B99-47B6-9ACA-F00809BCD191 Q36276986-46A2EE5E-1474-49C5-9575-CD7C6E8DEB2C Q36392698-5108D6EE-324B-4575-85EE-30F10F0F390B Q36509010-5015ED0A-63E5-49DB-B733-10AD2F262DE6 Q36545108-782A38BE-DE4F-4E19-9C37-DCF8E22B6D8B Q36774118-32F6473F-2574-4DB3-B44D-14AE131F53E0 Q36990777-14C5B23D-AB05-4CE9-BCD7-9135A5AD6643 Q37051417-394CCE1F-0DA4-4DBB-B423-4D614B154E79 Q37061910-02CC5E40-C72F-4E4B-A9AD-42969EAD1CF4 Q37210275-666ED1D8-3F82-4CEB-9C91-C596E59F70A1 Q37225665-D0815251-D17B-483F-B614-1A46F901B28D

P2860

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

http://www.wikidata.org/entity/Q35066321

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@ast

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@en

type

label

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@ast

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@en

prefLabel

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@ast

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@en

P1433

Q35066321-E19F9BDF-0D3B-4400-B4D7-B63E580A6612

P1476

Q35066321-7FE40381-FD39-489A-AB31-AB3923A8D113

P2093

Q35066321-09D43A8E-CB1A-433A-A727-7C4B5ABB971C

Q35066321-6A45658D-A1FA-4314-97DB-D735B5E11725

Q35066321-E98EABCF-6141-4EE4-8A2E-C5FCF956EF66

P2860

Q35066321-0201A83A-DD95-40D2-8F28-09778B624A2C

Q35066321-08713F50-F18F-40C6-B411-D0A86C221BB7

Q35066321-09C048E6-8BB5-4F32-A882-D760A36F2935

Q35066321-10616215-1599-4ABD-8760-9483B8FF32D2

Q35066321-15823932-54F7-4F6E-BCA5-5D2C344F83BF

Q35066321-1A0840EA-3339-4551-A382-7E6E775FC819

Q35066321-1D8A6AD6-2210-434A-A58E-D5BC640EB688

Q35066321-2013AAB7-184A-4CA6-9F93-C32E88FE21B5

Q35066321-26C4053F-A487-4313-997C-FA752D22D49C

Q35066321-30B2F15D-35DD-40D7-A281-63D8940D4FC2

P304

Q35066321-E6A31565-9F0F-46AD-B8BD-15BFEC4ABBE2

P31

Q35066321-98E7BCF5-EF93-4783-8101-DE06BA11D45B

P356

Q35066321-FC145748-DE23-425D-9E98-46E55B121B53

P433

Q35066321-65961F19-607E-4BA8-B67B-4D9EA7121174

P478

Q35066321-D0FD8B19-B378-4C3F-B9D6-452FF6240EDF

P577

Q35066321-5473927D-FFE3-49C4-87C1-8E43641E2212

P5875

Q35066321-D4D2FAB6-F4B7-454A-9C53-D9F9C3D82F3C

P698

Q35066321-BEB1A48F-1E3C-4543-9DDF-B7784E61F72F

P932

Q35066321-D239D97B-39D6-4ECB-8410-48C3F26A8574

P356

P1433

Contemporary oncology

P1476

The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge.

@en

P2093

Katarzyna Tomczak

http://www.w3.org/2001/XMLSchema#string

Maciej Wiznerowicz

http://www.w3.org/2001/XMLSchema#string

Patrycja Czerwińska

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Global cancer statistics

Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor

Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas

RNA-Seq: a revolutionary tool for transcriptomics

The Cancer Genome Atlas Pan-Cancer analysis project

Mutational heterogeneity in cancer and the search for new cancer-associated genes

MicroRNAs: target recognition and regulatory functions

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

miRNAs in human cancer

P304

A68-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2014.47136

http://www.w3.org/2001/XMLSchema#string

P433

1A

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272514319

http://www.w3.org/2001/XMLSchema#string

P698

25691825

http://www.w3.org/2001/XMLSchema#string

P932

4322527

http://www.w3.org/2001/XMLSchema#string